Brian A. Leuthner, President and CEO at Edge Therapeutics, Inc. (EDGE), sold 5,000 shares at $13.14 ($65K) on 2018-02-01, disclosed to the SEC on 2018-02-02.
Scheduled sale ($65k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.14 | 2,500 | $33K | 50.3% |
| 2 | $12.96 | 2,500 | $32K | 49.7% |
| Total | $13.05 avg | 5,000 | $65K | 100% |
| Filing → |
| EDGE | SELL | 2018-02-23 | $77K | — | Filing → |
| EDGE | SELL | 2018-01-03 | $51K | — | Filing → |
| EDGE | SELL | 2017-12-05 | $74K | — | Filing → |